NCT00490685View on ClinicalTrials.gov

Dose Escalation of Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)

PHASE2CompletedINTERVENTIONAL
Enrollment

142

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

June 30, 2008

Conditions
Carcinoma, Hepatocellular
Interventions
DRUG

Sorafenib (BAY-43-9006)

Trial Locations (1)

20089

Istituto Clinico Humanitas, Rozzano

All Listed Sponsors
lead

Istituto Clinico Humanitas

OTHER

NCT00490685 - Dose Escalation of Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC) | Biotech Hunter | Biotech Hunter